Fera Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Fera Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10505
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fera Pharmaceuticals LLC (Fera) is a pharmaceutical company that develops, markets and commercializes ointments and medicines. The company offers neptazane, bacitracin ophthalmic ointment USP, neo-polycin HC, and others. It offers various treatment options for patient and healthcare communities. Fera’s moxatag is a penicillin-class antibacterial product indicated for the treatment of tonsillitis and pharyngitis in adult and children. The company offers commercialization and marketing support for emerging pharmaceutical research and development. It also provides product development services. Fera is headquartered in Locust Valley, New York, the US.

Fera Pharmaceuticals LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Fera Pharma Amends Licensing Agreement with Nicox 10
Perrigo Enters Into Licensing Agreement With Fera Pharma For Neptazane 11
Asset Transactions 12
Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharma For Up To US$129 Million 12
Fera Pharmaceuticals LLC – Key Competitors 13
Fera Pharmaceuticals LLC – Key Employees 14
Fera Pharmaceuticals LLC – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 2
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fera Pharmaceuticals LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Fera Pharma Amends Licensing Agreement with Nicox 10
Perrigo Enters Into Licensing Agreement With Fera Pharma For Neptazane 11
Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharma For Up To US$129 Million 12
Fera Pharmaceuticals LLC, Key Competitors 13
Fera Pharmaceuticals LLC, Key Employees 14

List of Figures
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Fera Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Western Area Power Administration:企業の戦略的SWOT分析
    Western Area Power Administration - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Wheelock and Company Limited :企業の戦略・SWOT・財務情報
    Wheelock and Company Limited - Strategy, SWOT and Corporate Finance Report Summary Wheelock and Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Syros Pharmaceuticals Inc (SYRS):医療機器:M&Aディール及び事業提携情報
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • Xbrane Biopharma AB (XBRANE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • Noranda Income Fund (NIF.UN):企業の財務・戦略的SWOT分析
    Noranda Income Fund (NIF.UN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • InvitroCue Ltd (IVQ):企業の財務・戦略的SWOT分析
    Summary InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd, is a provider of bio-analytic solutions. The company provides digital pathology services such as digitization, sample preparation, staining, computer-aided diagnosis and consultation, telepathology, automated reporting and image a …
  • Genmedica Therapeutics SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Genmedica Therapeutics SL (Genmedica) is a clinical-stage biopharmaceutical company that researches, discovers and develops orally available NCEs for the treatment of diabetes. The company’s expertise spans provides development of specific, dual-action, small molecule inhibitors that targets …
  • Asn Bank
    Asn Bank - Strategy, SWOT and Corporate Finance Report Summary Asn Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • SMART Global Holdings, Inc. (SGH):企業の財務・戦略的SWOT分析
    SMART Global Holdings, Inc. (SGH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Aesculap Inc:企業の製品パイプライン分析2018
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • Bayer HealthCare Pharmaceuticals:医療機器:M&Aディール及び事業提携情報
    Summary Bayer HealthCare Pharmaceuticals (Bayer Healthcare), formerly Bayer Schering Pharma AG, a subsidiary of Bayer AG, is the pharmaceutical company that develops, manufactures and markets prescription products in the areas of general medicine and specialty medicine. The company offer prescriptio …
  • Allegra Orthopaedics Ltd (AMT):企業の財務・戦略的SWOT分析
    Allegra Orthopaedics Ltd (AMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Coastal Contacts Inc-医療機器分野:企業M&A・提携分析
    Summary Coastal Contacts Inc (Coastal Contacts), a subsidiary of Essilor International is an online retailer that markets eye care products. The company's products include eyeglasses, contact lenses, sunglasses, vision care accessories, and others. Its contact lenses comprise daily wear colour lense …
  • Pioneer Corporation (6773):企業の財務・戦略的SWOT分析
    Pioneer Corporation (6773) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • John Menzies plc:戦略・SWOT・企業財務分析
    John Menzies plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Japan Tobacco Inc (2914):製薬・医療:M&Aディール及び事業提携情報
    Summary Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes. It also manufactures, markets and sells varied pharmaceutical and processed food products such as frozen cooked rice and noodles, instant noodles, bread and frozen bread, mineral water, and seasoning, p …
  • CIMIC Group Limited:企業のM&A・事業提携・投資動向
    CIMIC Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIMIC Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • SenesTech Inc (SNES):企業の財務・戦略的SWOT分析
    SenesTech Inc (SNES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ginza Project:企業の戦略・SWOT・財務情報
    Ginza Project - Strategy, SWOT and Corporate Finance Report Summary Ginza Project - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析
    Jiangsu Hengrui Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆